Perspective Therapeutics Files Updated Corporate Presentation

What Happened Perspective Therapeutics, Inc. (NASDAQ: CATX) filed a Current Report on Form 8-K on August 3, 2026 (Item 8.01) to announce an updated corporate presentation. A copy of the presentation is attached to the filing as Exhibit 99.1 and is incorporated by reference into the report. The 8-K was signed by Joel Sendek, Chief Financial Officer.

Key Details

• Filing date: August 3, 2026 (Current Report on Form 8-K, Item 8.01).
• Exhibit filed: 99.1 — Corporate Presentation (updated).
• Administrative exhibit: 104 — Cover Page Interactive Data File embedded in the Inline XBRL document.
• Report signed by: Joel Sendek, Chief Financial Officer (dated Aug 3, 2026).

Why It Matters The filing makes Perspective Therapeutics’ updated corporate presentation publicly available for investors and analysts to review. While this 8-K does not report earnings, executive changes, or transactions, the presentation may contain refreshed information about the company’s strategy, programs, or milestones—investors should open Exhibit 99.1 in the SEC filing to see any substantive updates.